Public health & disease

From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.

Japanese flag, for article on Japan abortion pill

Japan approves first abortion pill

By / / Good News For Humankind

Japan’s first abortion pill won approval in 2023, and clinical trials there showed 93% of participants had a complete abortion within 24 hours using the two-pill combination. Until that vote, Japan had been one of the last developed nations offering only surgical options, including a method the World Health Organization calls obsolete. The ministry took the unusual step of opening a public comment period before deciding, drawing strong responses from doctors and advocates who had pushed for years. The approval is historic, though spousal consent requirements still shape who can actually access care. As reproductive rights contract in some countries and expand in others, Japan’s shift is a reminder that progress is uneven, hard-won, and worth celebrating wherever it lands.

Ghanaian child carrying load on head, for article on R21 malaria vaccine

Ghana first country to approve ‘world-changer’ malaria vaccine

By / / Good News For Humankind

Ghana’s approval of the R21 malaria vaccine — the first anywhere in the world — clears the way for children as young as five months to be protected against a disease that kills roughly 620,000 people every year, mostly young kids in Africa. Developed at Oxford’s Jenner Institute, R21 showed up to 80% effectiveness in early trials and is expected to cost just a couple of dollars per dose. The Serum Institute of India is preparing to produce up to 200 million doses a year, with a factory rising in Accra so supply stays close to home. After a century of scientific near-misses, an African regulator stepped forward and said: this one is ready.

Narcan nasal spray, for article on OTC naloxone

U.S. FDA approves over-the-counter sale of overdose reversal drug Narcan

By / / Good News For Humankind

Over-the-counter Narcan is now a reality: the FDA cleared the 4 mg naloxone nasal spray for sale at pharmacies, convenience stores, and other retailers without a prescription — the first opioid overdose reversal drug ever to earn that status in the U.S. The medication works within minutes to restore breathing, and it’s safe enough that any bystander can use it, no medical training required. For years, harm reduction workers quietly distributed naloxone in their communities, knowing how much it mattered; this decision finally meets them where they’ve been standing. Putting a life-saving tool on the same shelf as aspirin won’t end the overdose crisis on its own, but it’s a powerful reminder that expanding access — trusting ordinary people to help each other — is how public health movements actually save lives.